ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,653.11
0.39%
US Tech 100
19,758.00
-0.44%
다우존스 지수
40,874.21
1.65%
Bitcoin
64,722.81
-0.20%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Avadel Pharmaceuticals PLC (AVDL)

  7. Avadel Pharmaceuticals PLC (AVDL) 뉴스

AVDL

Avadel Pharmaceuticals (AVDL)

Avadel Pharmaceuticals PLC
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:AVDL
일자시간출처헤드라인심볼기업
2019/05/1706:02Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/05/1105:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/05/1105:39Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/05/0906:01Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/05/0905:12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/05/0820:00GlobeNewswire Inc.Avadel Pharmaceuticals Reports First Quarter 2019 Financial ResultsNASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/05/0106:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/05/0106:51Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/05/0105:42Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/05/0105:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/04/3005:30GlobeNewswire Inc.Avadel Pharmaceuticals to Report First Quarter 2019 Financial ResultsNASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/04/2921:00GlobeNewswire Inc.Avadel Pharmaceuticals Announces Appointment of Jordan Dubow, M.D., as Chief Medical OfficerNASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/03/1602:26Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/03/1520:00GlobeNewswire Inc.Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial ResultsNASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/03/1208:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/03/1208:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/03/1208:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/03/1208:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/03/0722:00GlobeNewswire Inc.Avadel Pharmaceuticals to Report Fourth Quarter and Full Year 2018 Financial ResultsNASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/02/1507:24Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/02/1506:27Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/02/1306:38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/02/1220:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/02/0806:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/02/0803:41GlobeNewswire Inc.Avadel Pharmaceuticals Clarifies Announcement of Corporate RestructuringNASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/02/0722:00GlobeNewswire Inc.Avadel Pharmaceuticals Announces Restructuring to Focus on FT218 Clinical Development ProgramNASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/01/2400:30GlobeNewswire Inc.‘Sleep Normal’ campaign urges Americans to end frequent nighttime urination and stop settling for nights of bad sleepNASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/01/1906:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/01/1102:55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2019/01/0406:45Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AVDLAvadel Pharmaceuticals PLC
 검색 관련기사 보기:NASDAQ:AVDL

최근 히스토리

NYSE
KO
Coca Cola
NASDAQ
QQQ
Invesco QQQ Trust Series 1
FX
USDGBP
US Dollar vs Sterling
COIN
BTCUSD
Bitcoin
NASDAQ
AMZN
Amazon.com
NASDAQ
TSLA
Tesla
USOTC
BNPQY
BNP Paribas (QX)
NYSE
VZ
Verizon Communications
NYSE
BAC
Bank of America
NASDAQ
GOOGL
Alphabet
USOTC
RHHBY
Roche (QX)
CCOM
US30
US 30
NYSE
DIS
Walt Disney
PM
XAUUSD
Gold vs US Dollar
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유